Michael W. Brands

11.8k total citations · 4 hit papers
134 papers, 9.0k citations indexed

About

Michael W. Brands is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Michael W. Brands has authored 134 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Endocrinology, Diabetes and Metabolism, 45 papers in Cardiology and Cardiovascular Medicine and 45 papers in Physiology. Recurrent topics in Michael W. Brands's work include Hormonal Regulation and Hypertension (25 papers), Diet and metabolism studies (24 papers) and Sodium Intake and Health (23 papers). Michael W. Brands is often cited by papers focused on Hormonal Regulation and Hypertension (25 papers), Diet and metabolism studies (24 papers) and Sodium Intake and Health (23 papers). Michael W. Brands collaborates with scholars based in United States, Germany and Netherlands. Michael W. Brands's co-authors include John E. Hall, Frank M. Sacks, Lawrence J. Appel, Njeri Karanja, Stephen R. Daniels, Eugene W. Shek, Michael Lefevre, Barbara V. Howard, Judith Wylie‐Rosett and H. L. Mizelle and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Michael W. Brands

133 papers receiving 8.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diet and Lifestyle Recommendations Revision 2006

2006 1.9k citations Alice H. Lichtenstein, Lawrence J. Appel et al. Circulation profile →
Dietary Approaches to Prevent and Treat Hypertension

2006 940 citations Lawrence J. Appel, Michael W. Brands et al. Hypertension profile →
Dietary Sugars Intake and Cardiovascular Health

2009 913 citations Lawrence J. Appel, Michael W. Brands et al. Circulation profile →
Chronic Leptin Infusion Increases Arterial Pressure

1998 581 citations Eugene W. Shek, Michael W. Brands et al. Hypertension profile →

Peers

Countries citing papers authored by Michael W. Brands

Since Specialization

Citations

This map shows the geographic impact of Michael W. Brands's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael W. Brands with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael W. Brands more than expected).

Fields of papers citing papers by Michael W. Brands

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael W. Brands. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael W. Brands. The network helps show where Michael W. Brands may publish in the future.

Co-authorship network of co-authors of Michael W. Brands

This figure shows the co-authorship network connecting the top 25 collaborators of Michael W. Brands. A scholar is included among the top collaborators of Michael W. Brands based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael W. Brands. Michael W. Brands is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A novel mouse model carrying a gene trap insertion into the Hmgxb4 gene locus to examine Hmgxb4 expression in vivo 2024 ·Physiological Reports ·Liang Wang, Xiangqin He, Guoqing Hu, Jinhua Liu, Xiuhua Kang, (unknown), Kunzhe Dong, (unknown), Aizhen Zhang, Wei Zhang, Michael W. Brands, Huabo Su, Zeqi Zheng, Jiliang Zhou	1
2	Dynamic Neuro-Glial-Vascular Responses in a Mouse Model of Vascular Cognitive Impairment 2024 ·SHILAP Revista de lepidopterología ·(unknown), Randolph E. Patterson, (unknown), Philip O’Herron, (unknown), (unknown), (unknown), Michael W. Brands, Zsolt Bagi, Jessica A. Filosa	1
3	Galectin-3 Mediates Vascular Dysfunction in Obesity by Regulating NADPH Oxidase 1 2023 ·Arteriosclerosis Thrombosis and Vascular Biology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Stephen Haigh, (unknown), (unknown), (unknown), James Mintz, (unknown), Ryan A. Harris, Michael W. Brands, David Fulton, David W. Stepp	10
4	Aldosterone Antagonism Is More Effective at Reducing Blood Pressure and Excessive Renal ENaC Activity in AngII-Infused Female Rats Than in Males 2023 ·Hypertension ·(unknown), (unknown), (unknown), (unknown), (unknown), Mary Cherian‐Shaw, Michael W. Brands, Jennifer C. Sullivan, Paul O’Connor, Mykola Mamenko	7
5	Postprandial effects on electrolyte homeostasis in the kidney 2019 ·American Journal of Physiology-Renal Physiology ·Christine A. Klemens, Michael W. Brands, Alexander Staruschenko	7
6	Postprandial Effects on ENaC-Mediated Sodium Absorption 2019 ·Scientific Reports ·Gregory Blass, Christine A. Klemens, Michael W. Brands, Oleg Palygin, Alexander Staruschenko	17
7	Reconstitution of autophagy ameliorates vascular function and arterial stiffening in spontaneously hypertensive rats 2019 ·American Journal of Physiology-Heart and Circulatory Physiology ·Cameron G. McCarthy, Camilla F. Wenceslau, Fabiano Beraldi Calmasini, (unknown), Michael W. Brands, Bina Joe, R. Clinton Webb	33
8	Waste gas scavenging during inhalational pediatric anesthesia in Belgium: results of a nationwide questionnaire survey 2018 ·Data Archiving and Networked Services (DANS) ·Michael W. Brands, M. Van de Velde, Jean-Paul Ory, (unknown), J. Berghmans, Jasperina Dubois, Luc Jamaer, Björn Stessel	1
9	Deletion of protein tyrosine phosphatase 1b in proopiomelanocortin neurons reduces neurogenic control of blood pressure and protects mice from leptin- and sympatho-mediated hypertension 2015 ·Pharmacological Research ·Thiago Bruder‐Nascimento, (unknown), (unknown), Michael W. Brands, Kendra K. Bence, Eric J. Belin de Chantemèle	21
10	l-Citrulline Protects from Kidney Damage in Type 1 Diabetic Mice 2013 ·Frontiers in Immunology ·Maritza J. Romero, Lin Yao, Supriya Sridhar, Anil Kumar Bhatta, Huijuan Dou, Ganesan Ramesh, Michael W. Brands, David M. Pollock, Ruth B. Caldwell, Stephen D. Cederbaum, C. Alvin Head, Zsolt Bagi, Rudolf Lucas, Robert W. Caldwell	36
11	Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension 2009 ·American Journal of Physiology-Renal Physiology ·Marlina Manhiani, Jeffrey E. Quigley, Sarah Knight, (unknown), (unknown), Michael W. Brands, Bruce D. Hammock, John D. Imig	122
12	Chronic glucose infusion causes sustained increases in tubular sodium reabsorption and renal blood flow in dogs 2008 ·American Journal of Physiology-Regulatory, Integrative and Comparative Physiology ·Michael W. Brands, (unknown), (unknown), (unknown), (unknown)	12
13	Continuously measured renal blood flow does not increase in diabetes if nitric oxide synthesis is blocked 2008 ·American Journal of Physiology-Renal Physiology ·(unknown), Gerald F. DiBona, (unknown), Michael W. Brands	17
14	LACK OF BLOOD PRESSURE SALT‐SENSITIVITY SUPPORTS A PREGLOMERULAR SITE OF ACTION OF NITRIC OXIDE IN TYPE I DIABETIC RATS 2007 ·Clinical and Experimental Pharmacology and Physiology ·Michael W. Brands, (unknown), Cassandra Fleming, Hicham Labazi, (unknown)	4
15	Diet and Lifestyle Recommendations Revision 2006 breakdown → 2006 ·Circulation ·Alice H. Lichtenstein, Lawrence J. Appel, Michael W. Brands, Mercedes R. Carnethon, Stephen R. Daniels, Harold A. Franch, Barry A. Franklin, Penny M. Kris‐Etherton, William S. Harris, Barbara V. Howard, Njeri Karanja, Michael Lefevre, Lawrence L. Rudel, Frank M. Sacks, Linda Van Horn, Mary Winston, Judith Wylie‐Rosett	1949
16	Renal 20-HETE inhibition attenuates changes in renal hemodynamics induced byl-NAME treatment in pregnant rats 2005 ·American Journal of Physiology-Renal Physiology ·Hui Huang, Yiqiang Zhou, (unknown), Juan Du, Hsin-Hsin Chang, Cong‐Yi Wang, Michael W. Brands, John R. Falck, Mong-Heng Wang	8
17	Chronic intravenous glucose infusion causes moderate hypertension in rats 2000 ·American Journal of Hypertension ·Michael W. Brands	28
18	ABNORMAL KIDNEY FUNCTION AS A CAUSE AND A CONSEQUENCE OF OBESITY HYPERTENSION 1998 ·Clinical and Experimental Pharmacology and Physiology ·John E. Hall, Michael W. Brands, Jeffrey R. Henegar, Eugene W. Shek	83
19	IS INSULIN RESISTANCE LINKED TO HYPERTENSION? 1998 ·Clinical and Experimental Pharmacology and Physiology ·Michael W. Brands, John E. Hall, Henry L. Keen	21
20	Resistance to Metabolic Actions of Insulin and Its Role in Hypertension 1994 ·American Journal of Hypertension ·John E. Hall, Richard L. Summers, Michael W. Brands, Henry L. Keen, Magdalena Alonso‐Galicia	60

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact